USFDA successfully completes audit at JB Chemicals and Pharma Gujarat facility Ruchika Sharma10 March 2025 11:15 AM ISTMumbai: J.B. Chemicals & Pharmaceuticals Limited has announced that the US Food and Drug Administration (USFDA) has successfully completed an...
JB Pharma reports 35 percent increase in PAT at Rs 142 crore in Q1 Ruchika Sharma10 Aug 2023 2:30 PM ISTNew Delhi: JB Chemicals & Pharmaceuticals Ltd on Wednesday reported a 35 per cent increase in profit after tax at Rs 142 crore in the first...
JB Chemicals and Pharma Gujarat facility concludes USFDA inspection with zero observations Ruchika Sharma12 Jun 2023 2:51 PM ISTGujarat: Pharma major, J.B. Chemicals & Pharmaceuticals Limited, has recently announced that the US Food and Drug Administration (USFDA) has...
JB Pharma acquires leading brand of Rosuvastatin- Razel and combinations Dr. Nandita Mohan20 Dec 2022 1:05 PM ISTNew Delhi: Leading brand of Rosuvastatin, Razel will now be offered from JB Pharma as the company has now entered into an agreement with Glenmark...
JB Pharma forays into Statin segment, acquires Razel franchise from Glenmark for Rs 314 crore Ruchika Sharma15 Dec 2022 4:00 PM ISTNew Delhi: JB Pharma, one of the fastest growing pharmaceutical companies in India, has entered into an agreement with Glenmark Pharmaceuticals...
Critical Heart Failure drug gets Cheaper, JB Pharma cuts prices of Azmarda by 50 percent Dr. Nandita Mohan8 Dec 2022 1:03 PM ISTMumbai: Treatment of Heart Failure will get more affordable in India, as makers of the heart failure drug Azmarda, JB pharma, has announced a...
JB Pharma slashes price of critical Heart Failure medicine AZMARDA (Sacubitril-Valsartan) by nearly 50 percent Ruchika Sharma5 Dec 2022 2:37 PM IST"This move by JB will not only help reduce the cost of treatment but will also help enhance the productive years of patients and their quality of...
JB Pharma bags USFDA nod for Major Depressive Disorder drug Venlafaxine Extended Release Ruchika Sharma30 Nov 2022 3:30 PM ISTA selective serotonin and norepinephrine reuptake inhibitor (SNRI), Venlafaxine Extended-Release tablets are indicated for Major Depressive Disorder...
JB Pharma records revenue growth of 36 percent to Rs 809 crores in Q2 FY23 Ruchika Sharma12 Nov 2022 12:35 PM ISTOperating EBITDA* grew by 44% to INR 202 crores
JB pharma strengthens its position in gastroenterology with launch of RANRAFT Roshni Dhar8 Nov 2022 6:00 PM ISTGastroesophageal reflux disease (GERD), affects up to 1 in 5 Indian patients, causes heartburn, acid reflux and impacts the quality of life. It is...
JB Pharma strengthens its position in Gastroenterology with launch of RANRAFT Lalhmangaihkimi7 Nov 2022 1:54 PM ISTMumbai: Gastroesophageal reflux disease (GERD), affects up to 1 in 5 Indian patients, causes heartburn, acid reflux and impacts the quality of life....
JB Chemicals acquires 4 pediatric brands from Dr Reddys Roshni Dhar1 July 2022 5:48 PM ISTJ.B. Chemicals & Pharmaceuticals Limited (JB Pharma) has recently announced that the Board of Directors of the company has approved the...
